# ANVISA

Type: organization

Source: GetYourBrief — https://getyourbrief.com/entity/anvisa-organization
Canonical HTML page: https://getyourbrief.com/entity/anvisa-organization

## Timeline

- **2027-01-01**: Implementation Phase — Expected start of streamlined registration for priority therapeutic categories.
- **2026-06-15**: Technical Working Group (Projected) — First meeting of regulatory experts to define GMP inspection sharing protocols.
- **2026-03-24**: Brazil Patent Grant — Recce Pharmaceuticals officially receives patent grant from the Brazilian National Institute of Industrial Property (INPI).
- **2026-02-22**: Bilateral Briefing — Government representatives outline the scope of pharmaceutical and medical product alignment.
- **2026-02-22**: Formal Announcement — Official confirmation of the bilateral agreement to strengthen medical product regulation.
- **2026-02-21**: MoU Exchange — Official documents exchanged between India and Brazil to initiate regulatory cooperation.
- **2026-02-21**: MoU Exchange Initiated — Initial diplomatic exchange of the regulatory cooperation framework in New Delhi.
- **2025-11-15**: Clinical Expansion — Recce expands Phase II clinical trials for RECCE® 327 in topical and intravenous applications.
- **2024-06-10**: US Patent Milestone — Recce secures key composition of matter patents in the United States, strengthening its North American position.

## Recent coverage (3 stories, network-wide)

### Recce Pharmaceuticals Secures Key Brazilian Patent for Anti-Infective Platform
2026-03-24 03:21:33 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Recce Pharmaceuticals has been granted a critical patent in Brazil for its synthetic anti-infective platform, marking a significant expansion into South America's largest healthcare market. The patent protects the composition and manufacturing of its lead candidates, RECCE® 327 and RECCE® 529, as the company targets the global antimicrobial resistance crisis.
Full story: https://getlegalbrief.com/story/recce-pharmaceuticals-brazil-patent-grant-anti-infectives

### India and Brazil Ink Strategic Regulatory Pact for Pharma and MedTech
2026-02-22 12:33:22 · Sector: bio · Sentiment: Positive · Impact: 6/10 · Sources: 2

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize regulatory standards for pharmaceutical and medical products. This bilateral agreement aims to streamline market access and enhance technical cooperation between two of the world's most influential emerging healthcare markets.
Full story: https://getbiobrief.com/story/india-brazil-pharma-regulatory-mou-2026

### India and Brazil Ink Regulatory Pact to Streamline Pharma and MedTech Trade
2026-02-22 12:32:48 · Sector: health · Sentiment: Positive · Impact: 6/10 · Sources: 2

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize the regulation of pharmaceutical and medical products. This strategic partnership aims to enhance bilateral cooperation, streamline market entry for life sciences companies, and ensure the safety and efficacy of medical goods exchanged between the two major emerging economies.
Full story: https://gethealthbrief.com/story/india-brazil-pharma-regulatory-mou-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.